Capital Markets: Derivatives & Structured Products | Asia-Pacific

Linklaters has a truly region-wide offering with large pools of resources and expertise in Greater China, Japan, Singapore, South Korea and Thailand, in addition to robust activity in the India and Indonesia markets. The team represents blue-chip clients in a comprehensive range of DCM matters, including convertible and exchangeable bond offerings and vanilla investment-grade debt issuances. Additionally, the firm maintains a notable ECM practice advising on IPOs, block trades and secondary offerings in a number of key jurisdictions. In addition, it has a comprehensive derivatives, securities and structured products practice.

A&O Shearman is reputed as a go-to firm for a wide variety of capital markets mandates, with particular strength in complex cross-border debt and hybrid product work. It is well recognised for handling a solid line-up of cross-border high-yield offerings. The firm is also very skilled at advising on equity issuances in the region. It is especially well respected in the major hubs of Hong Kong, Australia and Singapore, and additionally maintains a strong presence across the South-East Asia region, where it has standout practices in India, Thailand and Indonesia. It maintains a highly rated Hong Kong securitisation and derivatives practice, supported by resources in Singapore. The practice is highly experienced in advising on matters relating to the education, energy and manufacturing sectors. The firm is valued for US law expertise across the region, particularly advising on SEC compliance.

Clifford Chance is a major international firm with an exceptional track record of handling traditional equity and debt transactions throughout the Asia-Pacific region. It has particular ECM expertise located in Hong Kong, Singapore and Malaysia, advising on headline IPOs, listings and secondary issuances. It has leading investment-grade practices in China, South-East Asia and Japan, and is familiar with green, sovereign and convertible bond offerings. The firm often advises major international banks and Asian financial institutions on large-scale MTN programmes. It is also well respected for its ability to handle structured products and derivatives matters, regularly advising on regulatory changes and developments.

Latham & Watkins is hugely respected for its very strong high-yield practice and has recently been highly active in this area in Hong Kong, India and Singapore. It also has a very strong practice across the region, working on investment-grade debt and equity offerings including IPOs, hybrid products and secondary offerings. The firm additionally offers strong expertise in the OTC derivatives space, including futures, options and swaps work and in relation to structured equity and margin finance transactions. The team acts for a solid roster of blue-chip clients on high-profile deals throughout Indonesia, the Philippines and Thailand. It advises an enviable roster of international underwriters and notable corporate issuers. The firm is particularly active on issuances in the energy, technology and healthcare sectors.

Simmons & Simmons is respected for its work in the derivatives and structured products sphere, with OTC derivatives, CDOs and equity-linked products being areas of expertise. The firm is also deeply experienced in advising on regulatory compliance and development. Singapore is the primary base for the practice, from where the team represents clients across Asia-Pacific, including transactions involving Tokyo, Hong Kong, Beijing, Shanghai and Shenzhen. It advises a standout selection of international investment banks and regional fund managers as well as securities houses.